Please provide more context, and I'll do my best to assist you in preparing a text about it.
JUQ-446 represents a potent addition to the library of novel tryptamines. While it offers interesting possibilities for neuropharmacological research, the lack of long-term clinical data presents significant risks regarding its unsanctioned use. Regulatory bodies are advised to monitor its prevalence to prevent public health crises associated with unregulated NPS markets. Juq-446